课题基金 / 基金详情

PHASE II EVALUATION OF TOPOTECAN IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS

PHASE II EVALUATION OF TOPOTECAN IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
拓扑替康治疗儿科中枢神经系统肿瘤的 II 期评估
批准号:
3764432
负责人:
PETER PHILLIPS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

PETER PHILLIPS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purposes of this study are to determine the objective response rate and evaluate the steady state blood and CSF levels of the active metabolites of topotecan,an anticancer agent being studied in phase II trials. Knowledge of drug concentrations will permit us to optimize treatment schedules and knowledge of the response rate will allow us to know if this agent should be included in phase III survival studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I/II STUDY OF CI 980 IN ADULTS W/ NEWLY DIAGNOSED MALIGNANT GLIOMA
  • 批准号:
    6263600
  • 项目类别:
  • 资助金额:
    $2.51万
  • 财政年份:
    1998
  • 负责人:
    PETER PHILLIPS
  • 依托单位:
TEMOZOLOMIDE IN TREATMENT OF ANAPLASTIC ASTROCYTOMA AT FIRST RELAPSE
  • 批准号:
    6244474
  • 项目类别:
  • 资助金额:
    $2.36万
  • 财政年份:
    1997
  • 负责人:
    PETER PHILLIPS
  • 依托单位:
EARLY DETECTION OF NF 1 BRAIN TUMOR GROWTH AND TREATMENT RESPONSE
  • 批准号:
    6247973
  • 项目类别:
  • 资助金额:
    $2.32万
  • 财政年份:
    1997
  • 负责人:
    PETER PHILLIPS
  • 依托单位:
PHASE I/II STUDY OF CI 980 IN ADULTS W/ NEWLY DIAGNOSED MALIGNANT GLIOMA
  • 批准号:
    6303303
  • 项目类别:
  • 资助金额:
    $2.51万
  • 财政年份:
    --
  • 负责人:
    PETER PHILLIPS
  • 依托单位:
海外基金